Reach Us +44-7482878454
HIV Treatment as Prevention and the Role of Applied Social Science Research | OMICS International | Abstract
ISSN 2155-6113

Journal of AIDS & Clinical Research
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


HIV Treatment as Prevention and the Role of Applied Social Science Research

Will Small and Thomas Kerr*

Associate Professor, Department of Medicine, University of British Columbia, St. Paul’s Hospital, 608-1081 Burrard Street, Vancouver, British Columbia, Canada

*Corresponding Author:
Dr. Thomas Kerr, PhD
Director, Urban Health Research Initiative
British Columbia Centre for Excellence in HIV/AID
Associate Professor, Dept. of Medicine
University of British Columbia, St. Paul’s Hospital
608- 1081 Burrard Street, Vancouver
British Columbia,Canada, V6Z 1Y6
Tel: 604-806- 9116
Fax: 604-806-9044
E-mail: [email protected]

Received Date: November 23, 2011; Accepted Date: November 24, 2011; Published Date: November 28, 2011

Citation: Small W, Kerr T (2011) HIV Treatment as Prevention and the Role of Applied Social Science Research. J AIDS Clinic Res 2:102e. doi:10.4172/2155-6113.1000102e

Copyright: © 2011 Small W, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Utilizing highly active antiretroviral therapy (HAART) to reduce HIV transmission, commonly referred to as "treatment as prevention" (TASP), has been hailed as a valuable addition to comprehensive HIV prevention efforts [1]. Subsequent to the HPTN 052 trial [2], which established the efficacy of this approach, there have been calls to prioritize TasP within global HIV prevention efforts [3]. However, some have argued that the increasing emphasis on this form of biomedical prevention represents a "remedicalisation" of the HIV epidemic [4]. Concerns have been expressed that TasP will lead to the prioritization of biomedical solutions at the expense of other preventive approaches, detract attention from the social and material conditions that shape the epidemic, and lead to a proliferation of interventions deployed without adequate input from social scientists, community, and activists [4,5]. However, such critiques overlook growing attention to the social and structural dimensions of TasP [6], opportunities to link TasP with ongoing treatment advocacy efforts [7], as well as increasing recognition that the greatest reduction in the number of new HIV infections will be achieved by integrating biomedical, social, and structural interventions in comprehensive prevention programs

Recommended Conferences
Share This Page